Magnesium for PLMD: The Evidence Does Not Support Its Use
The 2025 American Academy of Sleep Medicine (AASM) clinical practice guideline does not recommend magnesium for the treatment of PLMD in adults, and no specific form of magnesium has been validated for this condition. 1
Why Magnesium Is Not Recommended
The most recent and authoritative guideline on PLMD treatment—the 2025 AASM guideline—conducted a comprehensive systematic review and does not include magnesium among its treatment recommendations for PLMD 1. The guideline only suggests against valproic acid and against triazolam for PLMD, but notably makes no recommendations for or against magnesium, indicating insufficient evidence to support its use 1.
What the Research Actually Shows
While there is limited research on magnesium for related conditions (RLS, not PLMD specifically), the evidence is weak:
A 2024 open-label pilot study using magnesium citrate 200 mg daily showed some improvement in RLS symptoms, but this was an uncontrolled study without placebo comparison, making the results unreliable 2
An older 1998 open pilot study (12.4 mmol magnesium in the evening) showed some reduction in periodic limb movements, but again lacked placebo control 3
Most importantly, a 2019 systematic review concluded: "We were unable to make a conclusion as to the effectiveness of magnesium for RLS/PLMD. It is not clear whether magnesium helps relieve RLS or PLMD" 4
What You Should Actually Do for PLMD
The 2025 AASM guideline provides clear direction for PLMD management:
Rule out other sleep disorders first: PLMD diagnosis requires excluding RLS, untreated obstructive sleep apnea, REM sleep behavior disorder, and narcolepsy—all of which can cause periodic limb movements 1
Address exacerbating factors: The guideline emphasizes addressing contributing factors as the first management step 1
Consider iron status: While not specifically recommended for isolated PLMD, iron deficiency is relevant in the broader context of sleep-related movement disorders 1
Avoid ineffective treatments: The guideline specifically recommends against valproic acid and triazolam for PLMD 1
Critical Caveat
PLMD is a diagnosis of exclusion—the periodic limb movements must directly cause sleep disturbance or daytime dysfunction, and other explanations must be ruled out 1. Many patients with frequent limb movements actually have undiagnosed RLS or other conditions, which would change the treatment approach entirely.
If you're considering magnesium despite the lack of evidence, the only form studied in any detail is magnesium citrate, but even this has no placebo-controlled data supporting its efficacy 2, 3, 4.